Anapril/Anapril-S

Anapril/Anapril-S

enalapril

Manufacturer:

Berlin Pharm

Distributor:

Berlin Pharm
Concise Prescribing Info
Contents
Enalapril maleate
Indications/Uses
Essential & renovascular HTN. Symptomatic CHF. Treatment & prevention of progression to symptomatic heart failure in clinically stable asymptomatic patients w/ left ventricular dysfunction.
Dosage/Direction for Use
Adult HTN Initially 5 mg once daily w/o concurrent diuretic or 2.5 mg once daily on existing diuretic. Maintenance: 10-40 mg once daily or in 2 divided doses. Symptomatic heart failure Initially 2.5 mg once daily or bid. Maintenance: 2.5-20 mg bid. Max: 40 mg daily in divided doses. Asymptomatic left ventricular dysfunction & MI Initially 2.5 mg bid. Maintenance: 2.5-10 mg bid. Max: 20 mg daily in divided doses. Patients w/ kidney disease (diabetic & non-diabetic) Initially 5 mg daily. Maintenance: 5-20 mg daily. Max: 20 mg daily. Patients w/ impaired renal function, moderate to severe impairment (CrCl ≤30 mL/min) Initially 2.5 mg daily. Max: 40 mg daily. Childn (6 mth-16 yr) HTN Initially 0.08 mg/kg (max: 5 mg) once daily. Maintenance: 0.08-0.58 mg/kg daily. Max: 0.58 mg/kg (40 mg) daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to enalapril or enalaprilat. Angioedema & those related to prior therapy w/ ACE inhibitor. Pregnancy.
Special Precautions
Discontinue if symptoms of angioneurotic edema of face, tongue, larynx or dyspnea develops. May induce coughing. Drowsiness or nausea/vomiting symptoms. History of CHF; risk of hypotension associated w/ oliguria &/or progressive azotemia; hyperkalemia. Patients w/ Na depletion or hypovolemia; receiving diuretics; undergoing dialysis; w/ left ventricle outflow tract obstruction eg, aortic stenosis, hypertrophic cardiomyopathy. Monitor renal function prior to treatment; for 1st few wk of therapy in patients w/ renal-artery stenosis. Concomitant use w/ K supplements, K-containing salt substitutes & K-sparing diuretics. Renal & hepatic impairment. Not recommended during lactation. Elderly.
Adverse Reactions
Renal function deterioration. Headache, dizziness; diarrhea, nausea; hypotension; rash, maculopapular rash; hyperkalemia; cough. Abdominal pain, vomiting, stomatitis, dyspepsia; pruritus, alopecia. Angioedema of face, lips, tongue, larynx, glottis or extremities; muscle cramps, pancreatitis, hepatitis or cholestatic jaundice, hepatic failure, impotence.
Drug Interactions
Increased hypotensive effect w/ diuretics & other antihypertensives. Concomitant use w/ K-sparing diuretics (eg, amiloride, spironolactone, triamterene), K supplements or K-containing salt substitutes; lithium. Reduced BP response w/ NSAIDs ie, aspirin, ibuprofen. Reduced fasting blood glucose conc w/ insulin. Exaggerated hypotensive response w/ some vasodilating agents (eg, nitrates) or anesth.
MIMS Class
ACE Inhibitors/Direct Renin Inhibitors
ATC Classification
C09AA02 - enalapril ; Belongs to the class of ACE inhibitors. Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Anapril tab 20 mg
Packing/Price
10 × 10's;100 × 10's
Form
Anapril tab 5 mg
Packing/Price
10 × 10's;100 × 10's
Form
Anapril-S tab 5 mg
Packing/Price
100 × 10's
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in